Covidien Endo Stitch suturing device found effective against benign conditions

1 December 2011 (Last Updated December 1st, 2011 18:30)

Covidien's Endo Stitch automated suturing device delivers a reduction in mean hospital costs and operating room time during total laparoscopic hysterectomies to treat benign conditions, a study has reported.

Covidien's Endo Stitch automated suturing device delivers a reduction in mean hospital costs and operating room time during total laparoscopic hysterectomies to treat benign conditions, a study has reported.

The study included a total of 5,731 patients who underwent laparoscopic hysterectomy, and compared the overall hospital costs and operating room time of treatments using the Endo Stitch with robotic techniques.

Half of the patients were treated with robotic assistance during their procedure, 13% with the Endo Stitch and the remaining 37% without either.

The results revealed that the Endo Stitch lowered overall hospitalisation costs by about $1,800 and reduced operating room time by around 40 minutes compared with robotic assistance.